| | Business Summary | | NeoRx
Corporation
is
developing
products
designed
to
provide
improved,
cost-effective
treatments
for
patients
with
cancer.
The
Company's
lead
product
candidate
is
named
Skeletal
Targeted
Radiotherapy
(STR).
The
Company
completed
enrollment
of
the
Phase
I/II
clinical
trials
of
STR
in
multiple
myeloma
in
2000.
NeoRx
is
also
developing
a
proprietary
Pretarget
technology
program
to
deliver
radiation
therapy,
and
potentially
other
anti-cancer
agents,
such
as
drugs
and
cytokines,
to
tumor
sites.
The
STR
product
uses
a
targeting
principle
to
deliver
a
specific
kind
of
radiation,
holmium-166,
to
bone,
where
it
is
designed
to
destroy
both
tumor
cells
and
normal
cells
in
the
marrow.
The
Pretarget
technology
program
employs
monoclonal
antibodies
to
target
cancer
cells.
Antibodies
are
proteins
produced
by
certain
white
blood
cells
in
the
body's
immune
system
in
response
to
antigens
(foreign
substances)
such
as
viruses,
bacteria,
toxins
and
specific
types
of
cancer
cells. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | NERX
is
engaged
in
developing
biopharmaceuticals
for
the
treatment
of
cancer,
with
a
primary
emphasis
on
improving
efficacy
and
reducing
toxicities.
For
the
six
months
ended
6/30/01,
revenues
increased
19%
to
$1.1
million.
Net
loss
applicable
to
Common
increased
45%
to
$9.4
million.
Revenues
reflect
the
recognition
of
government
grants.
Net
loss
reflects
a
decreased
realized
gain
on
the
sale
of
shares
of
Angiotech
Pharmaceuticals,
Inc. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Frederick Craves, Ph.D., 55
Chairman | -- | Douglas Given, M.D., Ph.D.
Pres,
CEO, Director | -- | Wolfgang Oster
COO | -- | Becky Bottino, 52
VP,
Operations | $189K | Richard Ghalie
VP,
Medical and Regulatory Affairs | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/n/nerx.gif)